GSK says staying on sidelines in Astra, Pfizer fight
LONDON (Reuters) – GlaxoSmithKline is just an “interested observer” as U.S. drugmaker Pfizer battles to win British rival AstraZeneca in a potential $100 billion deal, GSK’s chief executive said on Wednesday.
Pimco’s Gross sees low returns, no bubbles in assets: letter
NEW YORK (Reuters) – Bill Gross, manager of the world’s largest bond fund at Pimco, said Wednesday the likelihood of 2 percent future cash returns indicated that, while assets are not in a bubble, they would deliver lower returns in future years.
Thomson Reuters profit beats on cost-cutting
(Reuters) – Thomson Reuters Corp reported higher-than- expected quarterly earnings, bolstered by cost-cutting, as revenue edged higher mainly because of acquisitions.
Poor lung drug sales hit GSK in first-quarter, CEO wary on M&A
LONDON (Reuters) – GlaxoSmithKline posted a 10 percent fall in quarterly sales on Wednesday, highlighting some of the industry pressures behind last week’s decision to trade more than $20 billion of assets with Swiss rival Novartis
U.S. private sector adds 220,000 jobs in April: ADP
NEW YORK (Reuters) – U.S. private employers added 220,000 workers in April, the highest amount since November and above analysts’ expectations, a report by a payrolls processor showed on Wednesday.
U.S. mortgage market index hits lowest since December 2000: MBA
NEW YORK (Reuters) – Applications for U.S. home mortgages fell last week to their lowest level since December 2000 as both refinancing and purchase applications declined, an industry group said on Wednesday.
Euro recovers as inflation eases pressure on ECB
LONDON (Reuters) – The euro recovered and the currency bloc’s government bonds retreated on Wednesday after euro zone inflation stayed just about strong enough to suggest the European Central Bank will take no action when it meets next week.
Euro zone bonds reverse as inflation rises, takes heat off ECB
LONDON (Reuters) – Euro zone bond yields reversed earlier gains on Wednesday after euro zone inflation cooled expectations that the European Central Bank would need to immediately loosen monetary policy to support the bloc’s fledgling growth.
Ryanair buys five more Boeing 737-800 planes
DUBLIN (Reuters) – Low cost carrier Ryanair said on Wednesday it had agreed to buy five more Boeing 737-800 aircraft, taking its order book to 180 new Boeing planes worth over $16 billion.
UK lawmakers plan to probe Pfizer pursuit of AstraZeneca
LONDON (Reuters) – British lawmakers intend to investigate U.S. drugmaker Pfizer’s planned $100 billion takeover of British rival AstraZeneca in a bid to ensure scientific research and jobs are protected.
